TY - JOUR
T1 - Endogenous Sex Hormones and Breast Density in Young Women
AU - Jung, Seungyoun
AU - Stanczyk, Frank Z.
AU - Egleston, Brian L.
AU - Snetselaar, Linda G.
AU - Stevens, Victor J.
AU - Shepherd, John A.
AU - Van Horn, Linda
AU - LeBlanc, Erin S.
AU - Paris, Kenneth
AU - Klifa, Catherine
AU - Dorgan, Joanne F.
N1 - Publisher Copyright:
© 2014 American Association for Cancer Research.
PY - 2015/2/1
Y1 - 2015/2/1
N2 - Methods: We conducted a cross-sectional study among 180 women ages 25 to 29 years old who participated in the Dietary Intervention Study in Children 2006 Follow-up Study. Eighty-five percent of participants attended a clinic visit during their luteal phase of menstrual cycle. Magnetic resonance imaging measured the percentage of dense breast volume (%DBV), absolute dense breast volume (ADBV), and absolute nondense breast volume (ANDBV). Multiple-linear mixed-effect regression models were used to evaluate the association of sex hormones and sex hormone-binding globulin (SHBG) with %DBV, ADBV, and ANDBV. Results: Testosterone was significantly positively associated with %DBV and ADBV. The multivariable geometric mean of %DBV and ADBV across testosterone quartiles increased from 16.5% to 20.3% and from 68.6 to 82.3 cm3, respectively (Ptrend ≤ 0.03). There was no association of%DBVor ADBV with estrogens, progesterone, non-SHBG-bound testosterone, or SHBG (Ptrend ≥ 0.27). Neither sex hormones nor SHBG was associated with ANDBV except progesterone; however, the progesterone result was nonsignificant in analysis restricted to women in the luteal phase. onclusions: These findings suggest a modest positive association between testosterone and breast density in young women. Impact: Hormonal influences at critical periods may contribute to morphologic differences in the breast associated with breast cancer risk later in life.Background: Breast density is a strong risk factor for breast cancer and reflects epithelial and stromal content. Breast tissue is particularly sensitive to hormonal stimuli before it fully differentiates following the first full-term pregnancy. Few studies have examined associations between sex hormones and breast density among young women.
AB - Methods: We conducted a cross-sectional study among 180 women ages 25 to 29 years old who participated in the Dietary Intervention Study in Children 2006 Follow-up Study. Eighty-five percent of participants attended a clinic visit during their luteal phase of menstrual cycle. Magnetic resonance imaging measured the percentage of dense breast volume (%DBV), absolute dense breast volume (ADBV), and absolute nondense breast volume (ANDBV). Multiple-linear mixed-effect regression models were used to evaluate the association of sex hormones and sex hormone-binding globulin (SHBG) with %DBV, ADBV, and ANDBV. Results: Testosterone was significantly positively associated with %DBV and ADBV. The multivariable geometric mean of %DBV and ADBV across testosterone quartiles increased from 16.5% to 20.3% and from 68.6 to 82.3 cm3, respectively (Ptrend ≤ 0.03). There was no association of%DBVor ADBV with estrogens, progesterone, non-SHBG-bound testosterone, or SHBG (Ptrend ≥ 0.27). Neither sex hormones nor SHBG was associated with ANDBV except progesterone; however, the progesterone result was nonsignificant in analysis restricted to women in the luteal phase. onclusions: These findings suggest a modest positive association between testosterone and breast density in young women. Impact: Hormonal influences at critical periods may contribute to morphologic differences in the breast associated with breast cancer risk later in life.Background: Breast density is a strong risk factor for breast cancer and reflects epithelial and stromal content. Breast tissue is particularly sensitive to hormonal stimuli before it fully differentiates following the first full-term pregnancy. Few studies have examined associations between sex hormones and breast density among young women.
UR - https://www.scopus.com/pages/publications/84922725136
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000349422500007&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1158/1055-9965.EPI-14-0939
DO - 10.1158/1055-9965.EPI-14-0939
M3 - Article
C2 - 25371447
SN - 1055-9965
VL - 24
SP - 369
EP - 378
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 2
ER -